A Genetically Encoded Diazirine Analogue for RNA-Protein Photo-crosslinking.

Dmytro Dziuba, Jan-Erik Hoffmann, Matthias W Hentze, Carsten Schultz

Journal: Chembiochem : a European journal of chemical biology 2021;21(1-2):88-93

PMID: 31658407

Abstract

Ultraviolent crosslinking is a key experimental step in the numerous protocols that have been developed for capturing and dissecting RNA-protein interactions in living cells. UV crosslinking covalently stalls dynamic interactions between RNAs and the directly contacting RNA-binding proteins and enables stringent denaturing downstream purification conditions needed for the enrichment and biochemical analysis of RNA-protein complexes. Despite its popularity, conventional 254 nm UV crosslinking possesses a set of intrinsic drawbacks, with the low photochemical efficiency being the central caveat. Here we show that genetically encoded photoreactive unnatural amino acids bearing a dialkyl diazirine photoreactive group can address this problem. Using the human iron regulatory protein 1 (IRP1) as a model RNA-binding protein, we show that the photoreactive amino acids can be introduced into the protein without diminishing its RNA-binding properties. A sevenfold increase in the crosslinking efficiency compared to conventional 254 nm UV crosslinking was achieved using the diazirine-based unnatural amino acid DiAzKs. This finding opens an avenue for new applications of the unnatural amino acids in studying RNA-protein interactions.

© 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA.

Address: European Molecular Biology Laboratory, Meyerhofstrasse 1, 69117, Heidelberg, Germany.; Department of Chemical Physiology and Biochemistry, Oregon Health and Science University, L334, 3181 SW Sam Jackson Park Road, Portland, OR, 97239-3098, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.